Bank of New York Mellon’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.14M Buy
69,374
+1,538
+2% +$90.3K ﹤0.01% 2220
2026
Q1
$2.59M Sell
67,836
-956
-1% -$30.3K ﹤0.01% 2681
2025
Q4
$1.5M Buy
68,792
+29,185
+74% +$606K ﹤0.01% 3007
2025
Q3
$850K Buy
39,607
+1,744
+5% +$39.1K ﹤0.01% 3303
2025
Q2
$971K Buy
37,863
+5,098
+16% +$149K ﹤0.01% 3137
2025
Q1
$1.2M Sell
32,765
-1,927
-6% -$66.3K ﹤0.01% 2955
2024
Q4
$1.06M Sell
34,692
-4,306
-11% -$143K ﹤0.01% 3123
2024
Q3
$1.47M Sell
38,998
-11,607
-23% -$447K ﹤0.01% 2914
2024
Q2
$2M Buy
50,605
+3,752
+8% +$121K ﹤0.01% 2790
2024
Q1
$1.57M Sell
46,853
-7,050
-13% -$237K ﹤0.01% 2899
2023
Q4
$1.8M Buy
53,903
+3,940
+8% +$127K ﹤0.01% 2889
2023
Q3
$1.57M Sell
49,963
-12,182
-20% -$383K ﹤0.01% 2943
2023
Q2
$1.97M Sell
62,145
-4,997
-7% -$161K ﹤0.01% 2848
2023
Q1
$2.22M Buy
67,142
+403
+0.6% +$13.2K ﹤0.01% 2749
2022
Q4
$2.15M Sell
66,739
-221
-0.3% -$7.52K ﹤0.01% 2824
2022
Q3
$2.39M Buy
66,960
+23,992
+56% +$996K ﹤0.01% 2735
2022
Q2
$1.76M Sell
42,968
-2,428
-5% -$118K ﹤0.01% 2907
2022
Q1
$2.63M Sell
45,396
-12,458
-22% -$682K ﹤0.01% 2787
2021
Q4
$3.4M Sell
57,854
-1,182
-2% -$71.8K ﹤0.01% 2674
2021
Q3
$3.58M Buy
59,036
+19,603
+50% +$1.15M ﹤0.01% 2657
2021
Q2
$2.37M Buy
39,433
+2,678
+7% +$134K ﹤0.01% 2887
2021
Q1
$1.73M Sell
36,755
-542
-1% -$22.3K ﹤0.01% 3004
2020
Q4
$1.4M Sell
37,297
-1,688
-4% -$55.6K ﹤0.01% 3047
2020
Q3
$1.27M Sell
38,985
-19,376
-33% -$820K ﹤0.01% 2970
2020
Q2
$2.65M Buy
58,361
+18,786
+47% +$960K ﹤0.01% 2519
2020
Q1
$1.81M Sell
39,575
-1,105
-3% -$50K ﹤0.01% 2601
2019
Q4
$1.76M Buy
40,680
+1,441
+4% +$58.7K ﹤0.01% 2887
2019
Q3
$1.42M Buy
39,239
+7,062
+22% +$298K ﹤0.01% 2942
2019
Q2
$1.51M Sell
32,177
-8,209
-20% -$347K ﹤0.01% 2970
2019
Q1
$1.42M Sell
40,386
-34,798
-46% -$1.37M ﹤0.01% 2965
2018
Q4
$2.81M Sell
75,184
-53,112
-41% -$2.08M ﹤0.01% 2574
2018
Q3
$4.35M Buy
128,296
+1,557
+1% +$45.6K ﹤0.01% 2471
2018
Q2
$3.16M Buy
126,739
+10,983
+9% +$306K ﹤0.01% 2609
2018
Q1
$3.46M Sell
115,756
-812
-0.7% -$27.2K ﹤0.01% 2527
2017
Q4
$3.74M Sell
116,568
-621
-0.5% -$20K ﹤0.01% 2489
2017
Q3
$3.49M Sell
117,189
-4,076
-3% -$112K ﹤0.01% 2515
2017
Q2
$2.83M Sell
121,265
-1,424
-1% -$33.1K ﹤0.01% 2637
2017
Q1
$2.68M Buy
122,689
+9,976
+9% +$226K ﹤0.01% 2666
2016
Q4
$2.54M Buy
112,713
+7,622
+7% +$184K ﹤0.01% 2708
2016
Q3
$2.41M Buy
105,091
+3,505
+3% +$78.3K ﹤0.01% 2643
2016
Q2
$2.17M Sell
101,586
-2,481
-2% -$78.1K ﹤0.01% 2669
2016
Q1
$3.57M Buy
104,067
+26,998
+35% +$713K ﹤0.01% 2358
2015
Q4
$2.12M Buy
77,069
+37,260
+94% +$1.02M ﹤0.01% 2683
2015
Q3
$1.19M Sell
39,809
-7,339
-16% -$240K ﹤0.01% 3079
2015
Q2
$1.99M Buy
47,148
+36,284
+334% +$1.71M ﹤0.01% 2919
2015
Q1
$543K Buy
+10,864
New +$528K ﹤0.01% 3577

Other funds holding ATEX

Bank of New York Mellon's ATEX Position: Q2 2026 in Review

Bank of New York Mellon increased its Anterix (ATEX) stake by 2.3% in Q2 2026, buying an estimated $90.3K and bringing the position to 69,374 shares worth $7.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2220.

Bank of New York Mellon first reported a position in ATEX in Q1 2015 and has held it in 46 quarters since. 65 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Bank of New York Mellon held 69,374 shares of Anterix worth $7.14M as of Q2 2026.
  • Bank of New York Mellon bought 1,538 Anterix shares in Q2 2026, an estimated $90.3K.
  • Anterix made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2220 holding.
  • Bank of New York Mellon first reported a position in Anterix in Q1 2015 and has held it in 46 quarters since.
  • 65 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.